返回期刊详情
European Urology Open Science
IF4.5
论文数1085
被引数1943
期刊论文 1085
发表时间
Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8.阿多古杜等人在《欧洲泌尿外科学报开放科学》2026年第92卷第10-8页发表的论文:高风险前列腺癌患者在接受根治性前列腺切除术且未接受新辅助激素治疗下的肿瘤学结局研究。
Reply to Xin Li and Yapeng Xing's Letter to the Editor re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register-based study. Eur Urol Open Sci 2026;90:92-100回复李欣和邢亚鹏致编辑的信:关于Nielsen N.K, Hjort P.B, Hansen E.B等人关于T1膀胱癌的亚分期和分层治疗的全国注册研究。欧洲泌尿外科学会开放科学杂志2026;90:92-100
Re: Yuxi Liu, Zhengqin Xiao, Hairong He, et al. Development of the Short Form of the Specific Module of QLICD-BPH (V2.0) for Assessing Quality of Life with Benign Prostatic Hyperplasia by Classical Test Theory, Item Response Theory, and Generalizability Theory. Eur Urol Open Sci 2026;91:32–40关于刘玉玺、肖正琴、何海荣等人关于利用经典测试理论、项目反应理论和概化理论研究良性前列腺增生生活质量特异性模块QLICD-BPH(V2.0)简表开发的回复。欧洲泌尿外科开放科学,2026;91:32–40
Reply to Drs. Bayraktar and İşler's Letter to the Editor re: Basadonna LM, Passarelli F, Graps G, et al. Music During Transperineal Prostate Biopsy (The VIVALDI Trial): A Few Questions on the Gap Between Self-reported Benefit and Objective Findings回复巴亚克塔尔和伊斯勒博士致编辑的信:关于巴萨多娜LM、帕萨雷利F、格拉普斯G等人关于经会阴前列腺活检期间的音乐(VIVALDI试验):关于自我报告益处与客观发现之间差距的几个问题

